Pharma & Biotech

Investors delivered a harsh verdict on Redcare Pharmacy's latest financial update, sending the online pharmacy's stock price plunging nearly 30%...

Investors are preparing for a significant week for BioNTech SE, with the release of its full-year 2025 financial results set...

For months, Eli Lilly has been the undisputed leader in the lucrative market for obesity and diabetes treatments, with its...

Ocugen's full-year 2025 financial results, released on March 4, 2026, underscore a period of intense clinical advancement. The company's pipeline...

Pfizer has achieved a significant milestone in the lucrative weight-loss medication sector, gaining regulatory approval for its drug in the...

Johnson & Johnson has secured a pivotal victory in the treatment of blood cancer, marking a significant advancement for both...

Skye Bioscience has scheduled the release of its full-year 2025 financial results alongside a strategic business update. The announcement is...

Adma Biologics is currently navigating a period of significant internal transformation. The company's renewed strategic emphasis is on strengthening its...

Profound Medical's latest financial report reveals a company in a pivotal transition phase. The medical technology firm released its fourth-quarter...

During a recent investor roadshow, healthcare conglomerate Fresenius provided a detailed look at its strategic priorities and risk assessment. The...